Primary |
Product Used For Unknown Indication |
35.4% |
Depression |
30.5% |
Drug Use For Unknown Indication |
9.6% |
Obsessive-compulsive Disorder |
4.6% |
Anxiety |
4.3% |
Major Depression |
2.8% |
Mental Disorder |
1.6% |
Schizophrenia |
1.5% |
Asthma |
1.3% |
Hypertension |
1.2% |
Suicide Attempt |
1.0% |
Pain |
0.9% |
Drug Exposure During Pregnancy |
0.8% |
Insomnia |
0.7% |
Psychotic Disorder |
0.7% |
Tourette's Disorder |
0.6% |
Depressed Mood |
0.6% |
Bipolar Disorder |
0.6% |
Postpartum Depression |
0.6% |
Migraine |
0.5% |
|
Completed Suicide |
10.4% |
Suicidal Ideation |
8.4% |
Serotonin Syndrome |
7.9% |
Vomiting |
7.2% |
Tremor |
7.0% |
Poisoning |
6.0% |
Drug Exposure During Pregnancy |
5.8% |
Respiratory Arrest |
5.3% |
Product Substitution Issue |
4.9% |
Suicide Attempt |
4.8% |
Toxicity To Various Agents |
4.2% |
Therapeutic Response Unexpected With Drug Substitution |
4.0% |
Drug Interaction |
3.9% |
Drug Ineffective |
3.5% |
Somnolence |
3.3% |
Death |
2.8% |
Weight Decreased |
2.8% |
Syncope |
2.6% |
Urticaria |
2.6% |
Drug Abuse |
2.5% |
|
Secondary |
Product Used For Unknown Indication |
33.1% |
Drug Use For Unknown Indication |
22.4% |
Depression |
16.2% |
Suicide Attempt |
5.1% |
Anxiety |
4.1% |
Obsessive-compulsive Disorder |
2.6% |
Pain |
2.1% |
Bipolar Disorder |
2.0% |
Dementia Alzheimer's Type |
1.8% |
Hypertension |
1.8% |
Mental Disorder |
1.2% |
Major Depression |
1.1% |
Insomnia |
1.1% |
Overdose |
0.9% |
Schizophrenia |
0.8% |
Drug Exposure During Pregnancy |
0.8% |
Ill-defined Disorder |
0.8% |
Psychotic Disorder |
0.8% |
Completed Suicide |
0.7% |
Tourette's Disorder |
0.6% |
|
Completed Suicide |
19.8% |
Toxicity To Various Agents |
11.1% |
Serotonin Syndrome |
8.6% |
Respiratory Arrest |
7.2% |
Death |
5.6% |
Vomiting |
5.3% |
Suicide Attempt |
5.2% |
Weight Increased |
4.2% |
Drug Abuse |
4.1% |
Drug Toxicity |
4.1% |
Suicidal Ideation |
4.0% |
Poisoning |
3.9% |
Cardio-respiratory Arrest |
3.0% |
Tremor |
2.6% |
Intentional Overdose |
2.6% |
Somnolence |
1.9% |
Drug Interaction |
1.8% |
Overdose |
1.8% |
Weight Decreased |
1.7% |
Intentional Drug Misuse |
1.6% |
|
Concomitant |
Product Used For Unknown Indication |
28.8% |
Drug Use For Unknown Indication |
15.3% |
Depression |
13.3% |
Hypertension |
5.8% |
Pain |
5.0% |
Rheumatoid Arthritis |
5.0% |
Anxiety |
4.6% |
Multiple Sclerosis |
2.3% |
Schizophrenia |
2.2% |
Diabetes Mellitus |
2.0% |
Bipolar Disorder |
2.0% |
Insomnia |
1.9% |
Blood Cholesterol Increased |
1.8% |
Gastrooesophageal Reflux Disease |
1.8% |
Asthma |
1.5% |
Crohn's Disease |
1.4% |
Contraception |
1.4% |
Osteoporosis |
1.3% |
Hepatitis C |
1.3% |
Prophylaxis |
1.3% |
|
Weight Increased |
12.9% |
Vomiting |
12.3% |
Weight Decreased |
7.2% |
Pain |
5.5% |
Tremor |
5.5% |
Urinary Tract Infection |
5.4% |
Pulmonary Embolism |
5.2% |
Vision Blurred |
4.9% |
Suicidal Ideation |
4.5% |
Drug Ineffective |
4.2% |
Type 2 Diabetes Mellitus |
4.1% |
Withdrawal Syndrome |
3.7% |
Suicide Attempt |
3.5% |
Nausea |
3.3% |
Pneumonia |
3.3% |
Pain In Extremity |
3.3% |
Somnolence |
3.1% |
White Blood Cell Count Decreased |
2.8% |
Wheezing |
2.7% |
Renal Failure Acute |
2.7% |
|
Interacting |
Depression |
21.1% |
Product Used For Unknown Indication |
13.1% |
Tourette's Disorder |
10.3% |
Anxiety |
7.2% |
Drug Use For Unknown Indication |
6.5% |
Lower Respiratory Tract Infection |
5.4% |
Bladder Irritation |
4.4% |
Obsessive-compulsive Disorder |
4.2% |
Pollakiuria |
3.8% |
Mental Disorder |
2.9% |
Anaesthesia |
2.8% |
Major Depression |
2.6% |
Hypertension |
2.5% |
Constipation |
2.0% |
Insomnia |
2.0% |
Narcolepsy |
2.0% |
Somnolence |
2.0% |
Maintenance Of Anaesthesia |
1.8% |
Migraine |
1.8% |
Schizophrenia, Paranoid Type |
1.8% |
|
Drug Interaction |
25.3% |
Serotonin Syndrome |
15.4% |
Epilepsy |
9.3% |
Tourette's Disorder |
8.0% |
Toxicity To Various Agents |
5.6% |
Weight Increased |
4.9% |
Pollakiuria |
4.3% |
Tremor |
4.3% |
Drug Toxicity |
3.1% |
Hypomania |
2.5% |
Parkinsonism |
2.5% |
Physical Disability |
2.5% |
Emotional Disorder |
1.9% |
Micturition Disorder |
1.9% |
Pulmonary Oedema |
1.9% |
Respiratory Failure |
1.9% |
Cognitive Disorder |
1.2% |
Delirium |
1.2% |
Depression |
1.2% |
Drug Level Above Therapeutic |
1.2% |
|